NIH #3P30CA016672-49S1
Cancer Center Support Grant
- Amount
- $19K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P30CA016672-49
Leadership, Planning and Evaluation
- Amount
- $101K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-48S2
Cancer Center Support Grant
- Amount
- $204K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-48S1
Cancer Center Support Grant
- Amount
- $204K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-48S4
Developing Automated tools for Cervical Cancer Radiotherapy Treatment for Zambian Women living with HIV (Biospecimen/Cohort)
- Amount
- $232K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-48S3
CCSG Supplement: Early-Stage Surgeon Scientist (ESSP)
- Amount
- $204K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #4P30CA016672-48
Cancer Center Support Grant
- Amount
- $11.3M
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P50CA100632-20S1
Project 5: Targeting Oxidative Phosphorylation in AML
- Amount
- $286K
- Period
- 2023-09-01 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA100632-20
Project 5: Targeting Oxidative Phosphorylation in AML
- Amount
- $223K
- Period
- 2003-08-05 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-47S2
CCSG Supplement: Early-stage Surgeon Scientist Program (ESSP) - Chibawanye Ene
- Amount
- $203K
- Period
- 1996-08-28 → 2024-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P30CA016672-47
Cancer Center Support Grant
- Amount
- $11.0M
- Period
- 1996-08-28 → 2024-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-47S3
CCSG Supplement: Strengthen the Research, Training, and Outreach Capacity
- Amount
- $200K
- Period
- 1996-08-28 → 2024-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3P30CA016672-47S1
Cancer Center Support Grant
- Amount
- $202K
- Period
- 1996-08-28 → 2024-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218139-05
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
- Amount
- $357K
- Period
- 2018-02-01 → 2024-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA100632-19
Project 5: Targeting Oxidative Phosphorylation in AML
- Amount
- $223K
- Period
- 2003-08-05 → 2023-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA100632-18
Project 5: Targeting Oxidative Phosphorylation in AML
- Amount
- $234K
- Period
- 2003-08-05 → 2023-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218139-04
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
- Amount
- $365K
- Period
- 2018-02-01 → 2023-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218139-03
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
- Amount
- $365K
- Period
- 2018-02-01 → 2023-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218139-02
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
- Amount
- $354K
- Period
- 2018-02-01 → 2023-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #1R01CA218139-01A1
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
- Amount
- $379K
- Period
- 2018-02-01 → 2023-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA100632-17
Project 5: Targeting Oxidative Phosphorylation in AML
- Amount
- $236K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~3 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #2P50CA100632-16
Project 5: Targeting Oxidative Phosphorylation in AML
- Amount
- $215K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~3 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR